Matches in Ubergraph for { <https://frink.apps.renci.org/.well-known/genid/B262532382d15a40137d6fb1acc9cf92e> ?p ?o ?g. }
Showing items 1 to 5 of
5
with 100 items per page.
- B262532382d15a40137d6fb1acc9cf92e NCIT_P378 "CDISC-GLOSS" @default.
- B262532382d15a40137d6fb1acc9cf92e type Axiom @default.
- B262532382d15a40137d6fb1acc9cf92e annotatedProperty NCIT_P325 @default.
- B262532382d15a40137d6fb1acc9cf92e annotatedSource NCIT_C165823 @default.
- B262532382d15a40137d6fb1acc9cf92e annotatedTarget "A type of master protocol designed to test a single investigational drug or drug combination in different populations defined by disease stage, histology, number of prior therapies, genetic or other biomarkers, or demographic characteristics. [After FDA DRAFT Guidance: Master Protocols: Efficient Clinical Trial Design Strategies to Expedite Development of Oncology Drugs and Biologics. September 2018 and Woodcock J, LaVange LM. Master Protocols to Study Multiple Therapies, Multiple Diseases, or Both. N Engl J Med. 2017 Jul 6;377(1):62-70.] See also master protocol." @default.